Sinai Health System
$50,820.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- December 16, 2020 – May 31, 2021
- Reference
- nrc-cnrc:172-2020-2021-Q3-963520
Published purpose
Several rACE2-Fc molecules that have far higher affinity to the COVID19 viral spike RBD than the host ACE2 are being produced and purified by the NRC and collaborator JN Nova but a strategy for the selection of the best molecules to advance to preclinical trials is required. This Project aims at testing the proteins for their ability to neutralize viral entry using two assays developed at the Lunenfeld-Tanenbaum Research Institute, which are shown to be representative of the COVID19 viral infectivity mechanism on order to identify best leads for further development.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions